AXQ Capital’s Lifestance Health LFST Stock Holding History

AXQ Capital’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-66,262	Closed	-$343K	–	719
2025 Q2	$343K	Buy	+66,262	New	+$397K	0.11%	320

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AXQ Capital's LFST Position: Q3 2025 in Review

AXQ Capital sold out of Lifestance Health (LFST) in Q3 2025, closing a stake of 66,262 shares — an estimated $343K sold.

AXQ Capital first reported a position in LFST in Q2 2025 and held it in 1 quarter. The position peaked at $343K in Q2 2025. 210 funds tracked by Wall St. Rank hold LFST as of Q3 2025.

AXQ Capital reported no remaining Lifestance Health position as of Q3 2025 after selling out during the quarter.
AXQ Capital sold 66,262 Lifestance Health shares in Q3 2025, an estimated $343K.
AXQ Capital first reported a position in Lifestance Health in Q2 2025 and held it in 1 quarter.
AXQ Capital's Lifestance Health position peaked at $343K in Q2 2025.
210 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2025.

Based on AXQ Capital's 13F filing for Q3 2025, filed 10 Nov 2025.